Lidocaine patch transdermal (D. Western Therapeutics Institute/MEDRx)

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameLidocaine patch transdermal (D. Western Therapeutics Institute/MEDRx)
Drug Alias NameLydolyteBondlidoDW-5LBTMRX 5LBT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsNeuralgia, Postherpetic
Global Approved IndicationsNeuralgia, Postherpetic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/09/24
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesD. Western Therapeutics InstituteMEDRx Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTerrain Pharmaceuticals IncMEDRx Co LtdMedrx Usa Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia, Postherpetic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A